pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 3
    evorpacept
    evorpacept
    Adenocarcinoma Of The Gastroesophageal Junction$ALXO ALX ONCOLOGY HOLDINGS INC
  • Preclinical
    exRP-250
    Psoriasis exRNA Therapeutics Ltd
  • Phase 3
    exagamglogene autotemcel
    Casgevy (exagamglogene autotemcel)
    Beta Thalassaemia$VERX Vertex, Inc.
← prev
page 178 of 231
next →
131
Pain89
Neurology1
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOX Eloxx Pharmaceuticals, Inc.
  • Phase 1
    exarafenib
    exarafenib [INN]
    Melanoma Laboratoires Pierre Fabre SA
  • Phase 1
    exenatide
    Byetta (exenatide)
    Type 2 Diabetes$ORMP ORAMED PHARMACEUTICALS INC.
  • Phase 2
    exendin-(9-39)
    Hyperinsulinemia Children's Hospital of Philadelphia
  • Phase 2
    exeporfinium chloride
    exeporfinium chloride [INN]
    Hospital Acquired Methicillin-Resistant Staphylococcus au… AMR Bio Ltd
  • Phase 2
    ezeprogind
    ezeprogind [INN]
    Progressive Supranuclear Palsy AlzProtect SAS
  • Marketed
    ezetimibe
    Ezetimibe
    Heterozygous Familial Hypercholesterolemia (heFH) OEP Pharma
  • Phase 2
    ezurpimtrostat
    ezurpimtrostat [INN]
    Bile Duct Cancer (Cholangiocarcinoma) Genfit SA
  • Marketed
    factor IX complex
    Profilnine SD (factor IX complex)
    Hemophilia B (Factor IX Deficiency) Grifols Biologicals Inc (Inactive)
  • Marketed
    factor XIII (human)
    Corifact (factor XIII (human))
    Fibrin Stabilizing Factor Deficiency (Factor XIII Deficie… CSL Behring LLC
  • Phase 1
    faldoritinib
    faldoritinib
    Refractory Acute Myeloid Leukemia$BMEA Biomea Fusion, Inc.
  • Marketed
    famciclovir
    Famciclovir
    Genital Herpes Camber Pharmaceuticals Inc
  • Marketed
    famotidine
    Pepcid (famotidine)
    Acid Indigestion (Heartburn/Pyrosis)$KVUE Kenvue Inc.
  • Phase 2
    famzeretcel
    famzeretcel [INN]
    Retinitis Pigmentosa (Retinitis) jCyte Inc
  • Phase 1
    farabursen sodium
    farabursen sodium
    Polycystic Kidney Disease$NVS NOVARTIS AG
  • Phase 1
    faridoxorubicin
    faridoxorubicin [INN]
    Dedifferentiated Liposarcoma Avacta Life Sciences Ltd
  • Phase 2
    farletuzumab ecteribulin
    farletuzumab ecteribulin
    Triple-Negative Breast Cancer (TNBC) Eisai Co Ltd
  • Phase 3
    fasedienol
    Aloradine (fasedienol)
    Social Anxiety Disorder (SAD/Social Phobia)$VTGN Vistagen Therapeutics, Inc.
  • Phase 2
    fasudil
    BRAVYL (fasudil [INN])
    Amyotrophic Lateral Sclerosis Woolsey Pharmaceuticals Inc
  • Phase 3
    fazirsiran sodium
    fazirsiran sodium
    Alpha-1 Antitrypsin Deficiency (A1AD)$ARWR ARROWHEAD PHARMACEUTICALS, INC.
  • Phase 1
    fb-PMT
    Recurrent Glioblastoma Multiforme (GBM) NanoPharmaceuticals LLC
  • Marketed
    fecal microbiota, live-brpk
    Vowst
    Clostridioides difficile Infections (Clostridium difficil… Nestle HealthCare Nutrition Inc
  • Marketed
    fecal microbiota, live-jslm
    Rebyota
    Clostridioides difficile Infections (Clostridium difficil… Ferring Pharmaceuticals Inc
  • Marketed
    felbamate
    Felbamate Wallace (felbamate)
    Generalized Seizures Wallace Pharmaceuticals Inc
  • Marketed
    felodipine ER
    Felodipine
    Hypertension Method Pharmaceuticals LLC
  • Phase 3
    felzartamab
    felzartamab [INN]
    Membranous Glomerulonephritis$BIIB BIOGEN INC.
  • Phase 3
    fenebrutinib
    fenebrutinib
    Primary Progressive Multiple Sclerosis (PPMS) Genentech Inc